gadoterate meglumine

FDA Drug Profile — DOTAREM, Gadoterate Meglumine, CLARISCAN, gadoterate meglumine

Drug Details

Generic Name
gadoterate meglumine
Brand Names
DOTAREM, Gadoterate Meglumine, CLARISCAN, gadoterate meglumine
Application Number
NDA204781
Sponsor
Guerbet LLC
NDC Codes
14
Dosage Forms
INJECTION, INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients
GADOTERATE MEGLUMINE

Indications and Usage

1 INDICATIONS AND USAGE Gadoterate Meglumine Injection is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity. Gadoterate Meglumine Injection is a gadolinium-based contrast agent indicated: for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity. ( 1 )